Charis Eng
Impact in
- Cancer Research top 0.05%
- Cancer, Hypoxia, and Metabolism
- Endocrinology, Diabetes and Metabolism top 0.02%
- Thyroid Cancer Diagnosis and Treatment
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 230
- Cancer Research 109
- Cancer, Hypoxia, and Metabolism 42
- Co-authors
- Lois M. Mulligan (38 shared papers)Jessica L. Mester (36 shared papers)Kristin A. Waite (18 shared papers)Patricia L. M. Dahia (20 shared papers)Hartmut P.H. Neumann (29 shared papers)Joanne Yuen Yie Ngeow (34 shared papers)Mohammed S. Orloff (24 shared papers)Ramon E. Parsons (6 shared papers)
- Journals
- Human Molecular Genetics (44 papers)The Journal of Clinical Endocrinology & Metabolism (41 papers)The American Journal of Human Genetics (29 papers)Oncogene (21 papers)Journal of Medical Genetics (20 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Charis Eng
740 papers receiving 56.8k citations
Charis Eng's Hit Papers
Peers
Comparison fields: 5 of 185
- Cancer Research 9.7k
- Endocrinology, Diabetes and Metabolism 10.5k
- Oncology 9.9k
- Pathology and Forensic Medicine 6.5k
- Molecular Biology 26.0k
Countries citing papers authored by Charis Eng
This map shows the geographic impact of Charis Eng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charis Eng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charis Eng more than expected).
Fields of papers citing papers by Charis Eng
This network shows the impact of papers produced by Charis Eng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charis Eng. The network helps show where Charis Eng may publish in the future.
Co-authors
The 25 scholars most cited alongside Charis Eng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 764 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome Hit paper breakdown → | 1997 | 1686 |
| 2 | Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A Hit paper breakdown → | 1993 | 1639 |
| 3 | Germ-Line Mutations in Nonsyndromic Pheochromocytoma Hit paper breakdown → | 2002 | 1094 |
| 4 | Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association Hit paper breakdown → | 2009 | 1014 |
| 5 | Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma Hit paper breakdown → | 2001 | 937 |
| 6 | The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis Hit paper breakdown → | 1996 | 896 |
| 7 | Catalytic specificity of protein-tyrosine kinases is critical for selective signalling Hit paper breakdown → | 1995 | 837 |
| 8 | Essential Role for Nuclear PTEN in Maintaining Chromosomal Integrity Hit paper breakdown → | 2007 | 827 |
| 9 | 1997 | 686 | |
| 10 | Lifetime Cancer Risks in Individuals with GermlinePTENMutations Hit paper breakdown → | 2012 | 678 |
| 11 | The Relationship Between Specific RET Proto-oncogene Mutations and Disease Phenotype in Multiple Endocrine Neoplasia Type 2 Hit paper breakdown → | 1996 | 662 |
| 12 | 2005 | 643 | |
| 13 | 2003 | 639 | |
| 14 | Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma Hit paper breakdown → | 2017 | 605 |
| 15 | Germline mutations in PTEN are present in Bannayan-Zonana syndrome Hit paper breakdown → | 1997 | 561 |
| 16 | Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC Hit paper breakdown → | 1994 | 549 |
| 17 | 1996 | 512 | |
| 18 | 1999 | 468 | |
| 19 | Mortality From Second Tumors Among Long-Term Survivors of Retinoblastoma Hit paper breakdown → | 1993 | 463 |
| 20 | 1994 | 452 |
About Charis Eng
Charis Eng is a scholar working on Molecular Biology, Cancer Research, Genetics, Oncology and Endocrinology, Diabetes and Metabolism, having authored 764 papers that have together received 59.2k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (230 papers), BRCA gene mutations in cancer (70 papers), Genetic factors in colorectal cancer (68 papers), Adrenal and Paraganglionic Tumors (56 papers), Thyroid Cancer Diagnosis and Treatment (48 papers), Neuroendocrine Tumor Research Advances (46 papers), Cancer-related Molecular Pathways (45 papers) and Cancer, Hypoxia, and Metabolism (42 papers). The work is most often cited by research in Cancer Research (9.7k citations), Endocrinology, Diabetes and Metabolism (10.5k citations), Oncology (9.9k citations), Pathology and Forensic Medicine (6.5k citations) and Molecular Biology (26.0k citations). Charis Eng has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Lois M. Mulligan, Jessica L. Mester, Kristin A. Waite, Patricia L. M. Dahia, Hartmut P.H. Neumann, Joanne Yuen Yie Ngeow, Mohammed S. Orloff, Ramon E. Parsons, Catherine S. Healey and Zimu Zheng. Their work appears in journals such as Human Molecular Genetics, The Journal of Clinical Endocrinology & Metabolism, The American Journal of Human Genetics, Oncogene and Journal of Medical Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.